期刊文献+

2-(3-氰基-4-羟基)苯基-4-甲基-5-噻唑甲酸乙酯的合成 被引量:7

Synthesis of ethyl 2-(3-cyano-4-hydroxyphenyl)-4-methylthiazole-5-carboxylate
下载PDF
导出
摘要 目的优化非布司他关键中间体2-(3-氰基-4-羟基)苯基-4-甲基-5-噻唑甲酸乙酯(4)的合成方法。方法采用"一勺烩"方法,以4-羟基苯甲腈为起始原料,首先与硫氢化钠和无水氯化镁在N,N-二甲基甲酰胺中反应,所得中间体不经分离,直接加入2-氯乙酰乙酸乙酯进行环合反应,得到2-(4-羟基)苯基-4-甲基-5-噻唑甲酸乙酯(2);然后通过六亚甲基四胺/三氟乙酸进行Duff反应,得到2-(3-甲酰基-4-羟基)苯基-4-甲基-5-噻唑甲酸乙酯(3);再经盐酸羟胺/甲酸/甲酸钠体系脱水得到目标化合物。结果经四步反应合成非布司他关键中间体4,总收率为22.6%,其结构经核磁共振氢谱、质谱确证。结论改进后的工艺终产品无需柱色谱纯化,适合工业化生产。 Objective To optimize the synthetic method of ethyl 2-(3-cyano-4-hydroxyphenyl)-4-methylthiazole-5-carboxylate(4),a key intermediate for the synthesis of febuxostat.Methods 4-Hydroxy-benzonitrile was treated with sodium hydrogen sulfide and anhydrous magnesium chloride in dimethylformamide to give thioamide,which was then directly cyclized with ethyl 2-chloroacetoacetate without separation to give ethyl 2-(4-hydroxyphenyl)-4-methylthiazole-5-carboxylate(2) in one-pot;then 2 was formylated with Duff reaction adopting hexamethylenetetramine in trifluoroacetic acid to give ethyl 2-(3-formyl-4-hydroxyphenyl)-4-methylthiazole-5-carboxylate(3);finally,the target compound was obtained by the treatment of 3 with hydroxylamine hydrochloride and sodium formate in formic acid.Results The key intermediate 4 for the synthesis of febuxostat was synthesized via a four-step procedure in a total yield of 22.6% and its structure was confirmed by 1H-NMR and ESI-MS.Conclusions The improved process does not need column chromatography to purify and the end product is very suitable for industrial preparation.
出处 《沈阳药科大学学报》 CAS CSCD 北大核心 2010年第5期365-368,共4页 Journal of Shenyang Pharmaceutical University
关键词 非布司他 2-(3-氰基-4-羟基)苯基-4-甲基-5-噻唑甲酸乙酯 合成 febuxostat ethyl 2-(3-cyano-4-hydroxyphenyl)-4-methylthiazole-5-carboxylate synthesis
  • 相关文献

参考文献9

  • 1HACHIJI S K,HINO H F,HINO M H,et al. 2-arylthiazole derivatives and pharmaceutical composition thereof:US,5614520[P]. 1997 - 03 - 25.
  • 2BORGES F, FERNANDES E, ROLEIRA F. Progress towards the discovery of xanthine oxidase inhibitors [ J ]. Current Medicinal Chemistry, 2002,9 ( 2 ) : 195 - 217.
  • 3FERNANDO P R, NACOLA D, NAOMI S. Febuxostat,a novel drug for the treatment of hyperuricemia of gout [ J ]. Future Rheumatol,2008,3 (5) :421 - 427.
  • 4WATANABE K, TANAKA T, KONDO S, et al. Preparation of phenylthiazoles as pharmaceuticals: JP, 6329647 [P]. 1994 - 11 - 29.
  • 5ROBBINS T A, ZHU H, SHAO J. Substituted thiazoles: US ,2005027128 [ P]. 2005 - 02 - 03.
  • 6MIWATASHI S J,NARUO K I,IGAKI K K,et al. Synthesis and biological activities of 4-phenyl-5-pyridyl-1,3-thiazole derivatives as p38 MAP kinase inhibi- tors[ J ]. Chemical & Pharmaceutical Bulletin, 2005,53 (4) :410-418.
  • 7隋强,王小妹,王哲烽,等.2-(3-甲醛基-4-羟基)苯基-4-甲基-5-噻唑甲酸乙酯的制备方法:中国,101412699[P].2009-04-22.
  • 8MANAKA A, SATO M. Synthesis of aromatic thioamide from nitrile without handling of gaseous hydrogen sulfide[ J ]. Synthetic Communications, 2005,25 ( 3 ) : 761 -764.
  • 9王德才,唐春雷,米珊,等.一锅法制备2-(4-羟基)苯基-4-甲基-1,3-噻唑-5-羧酸乙酯的方法:中国,101391988[P].2009-03-25.

同被引文献61

引证文献7

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部